Central Nervous System Stimulants and Drugs That Suppress Appetite
Document Type
Book Contribution
Publication Date
1-1-2017
Description
The Side Effects of Drugs Annuals forms a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. The purpose of this supplement is to provide a concise reference of the newly available literature to support the existing information regarding the known adverse effects of commonly prescribed medications or abused drugs. The information covers peer-reviewed publications from January 2016 to December 2016. This review focused on CNS stimulants and drugs that suppress appetite. It covers amphetamines (including lisdexamfetamine, methamphetamine and 3,4-methylenedioxymetamphetamine), methylphenidate, atomoxetine, modafinil and armodafinil, methylxanthines (caffeine), monotherapies and combinational therapies that suppress appetite (lorcaserin, phentermine, phentermine/topiramate) and medications used in Alzheimer's disease and cognitive decline (rivastigmine, donepezil and memantine).
Citation Information
Bello, Nicholas T.; and Zahner, Matthew R.. 2017. Central Nervous System Stimulants and Drugs That Suppress Appetite. Side Effects of Drugs Annual. Vol.39 1-8. https://doi.org/10.1016/bs.seda.2017.07.007 ISSN: 0378-6080
